CHEMOTHERAPY OF INFECTIOUS DISEASES CAUSED BY INTRACELLULAR AGENTS Infectious Useful agents Diseases chemotherapeutic agents Bacteria

As is well known, effective chemotherapy is available for a large number of infectious diseases caused by bacteria multiplying extracellularly. Effective chemotherapy is also available for a considerable number of infectious diseases caused by intracellular agents. As shown in Table 1, typhoid fever and tuberculosis provide examples of treatable diseases caused by nonobligate intracellular bacterial agents. Diseases caused by rickettsiae, which are obligate intracellular parasites (e.g., epidemic typhus and Rocky Mountain spotted fever), respond satisfactorily to treatment with the various tetracyclines or chloramphenicol. Results obtained earlier with p-aminobenzoic acid were less impressive. Finally, treatment of psittacosis and lymphogranuloma venereum with the various tetracyclines also gives satisfactory results. Until recently the agents responsible for these and certain other diseases were classified with viruses. Actually, the Chlamydozoaceae, as this group of agents is now designated, seem to be more closely related to rickettsiae than to the so-called true viruses. The broad spectrum of effectiveness of the tetracyclines suggests that the therapeutic effects may be obtained through interference with a metabolic mechanism, probably biosynthetic, common to a wide variety of microbes. On the other hand, the parasite selective activity of p-aminobenzoic acid, penicillin, and sulfonamides emphasizes differences among the agents of epidemic typhus, psittacosis, and lymphogranuloma venereum. It is likely that these differences are also metabolic in nature. Available evidence indicates that the chemotherapeutic agents listed in Table 1 reduce the rate of multiplication of the various infectious agents. It is entirely possible, however, that in some instances the infecting agent is killed in the presence of the chemotherapeutic compound and not merely retarded. As the result of either mechanism, the number of infecting particles is kept relatively low. When the number is kept below a critical value for a given infection, symptoms and signs of disease may disappear or remain in abeyance.'3

[1]  D. Burke,et al.  The nucleic acid content of influenza virus. , 1957, Biochimica et biophysica acta.

[2]  K. Folkers,et al.  HIGH INHIBITORY ACTIVITY OF CERTAIN HALOGENATED RIBOFURANOSYLBENZIMIDAZOLES ON INFLUENZA B VIRUS MULTIPLICATION , 1956, Journal of bacteriology.

[3]  I. Tamm SELECTIVE CHEMICAL INHIBITION OF INFLUENZA B VIRUS MULTIPLICATION , 1956, Journal of bacteriology.

[4]  K. Folkers,et al.  CERTAIN BENZIMIDAZOLES, BENZENES, AND RIBOFURANOSYLPURINES AS INHIBITORS OF INFLUENZA B VIRUS MULTIPLICATION , 1956, Journal of bacteriology.

[5]  F. Horsfall Approaches to the chemotherapy of viral diseases. , 1955, Bulletin of the New York Academy of Medicine.

[6]  J. Nelson Acute hepatitis associated with mouse leukemia. V. The neurotropic properties of the causal virus. , 1955 .

[7]  Igor Tamm,et al.  Selective Inhibition of Virus Multiplication by Synthetic Chemicals. , 1955 .

[8]  D. J. Bauer The antiviral and synergic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice. , 1955, British journal of experimental pathology.

[9]  I. Tamm Inhibition of influenza and mumps virus multiplication by 4,5,6- (or 5,6,7-) trichloro-1-beta-D-ribofuranosyl-benzimidazole. , 1954, Science.

[10]  K. Folkers,et al.  INHIBITION OF INFLUENZA VIRUS MULTIPLICATION BY N-GLYCOSIDES OF BENZIMIDAZOLES , 1954, The Journal of experimental medicine.

[11]  Gordon C. Brown,et al.  Antiviral Action of a Mold Filtrate on Experimental Poliomyelitis in Gynomolgus Monkeys.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[12]  R. L. Thompson,et al.  Effect of Aliphatic Oxime and Isatin Thiosemicarbazones on Vaccinia Infection in the Mouse and in the Rabbit∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  K. Folkers,et al.  Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. II. Measurement of inhibitory activity by hemagglutination titrations. , 1953 .

[14]  C. Culbertson,et al.  Action of an Antiviral Mold Filtrate against MEFl Poliomyelitis Virus in Mice , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[15]  R. Shope An antiviral substance from Penicillium funiculosum. II. Effect of helenine upon infection in mice with Semliki Forest virus. , 1953 .

[16]  R. Shope AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : I. EFFECT UPON INJECTION IN MICE WITH SWINE INFLUENZA VIRUS AND COLUMBIA SK ENCEPHALOMYELITIS VIRUS , 1953 .

[17]  R. Shope An antiviral substance from Penicillium funiculosum. III. General properties and characteristics of helenine. , 1953 .

[18]  R. L. Thompson,et al.  Effect of heterocyclic and other thiosemicarbazones on vaccinia infection in the mouse. , 1953, Journal of immunology.

[19]  E. Hurst,et al.  The prevention of encephalitis due to the viruses of eastern equine encephalomyelitis and louping-ill: experiments with trypan red, mepacrine, and many other substances. , 1952, British journal of pharmacology and chemotherapy.

[20]  M. Hoehn,et al.  A filtrate with chemoprophylactic and chemotherapeutic action against MM and Semliki Forest viruses in mice. , 1952, Antibiotics & chemotherapy.

[21]  K. Folkers,et al.  Inhibition of Influenza Virus Multiplication by 2,5-Dimethylbenzimidazole * , 1952, The Yale journal of biology and medicine.

[22]  W. Ackermann α-Aminosulfonic Acids and Viral Propagation.∗ , 1952 .

[23]  R. L. Thompson,et al.  Protection of mice against the vaccinia virus by the administration of phenoxythiouracils. , 1951, Journal of immunology.

[24]  K. Brownlee,et al.  Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones. , 1951, Journal of immunology.

[25]  R. L. Thompson,et al.  Protection of Mice Against Vaccinia Virus by Administration of Benzaldehyde Thiosemicarbazone.∗ , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  C. Friend,et al.  Effect of 2,6-diaminopurine on the Course of Russian Spring-Summer Encephalitis Infection in the Mouse.∗ , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[27]  C. W. Jungeblut Chemotherapeutic Effects of a Naphthoquinonimine on Infection of Mice with Columbia-SK Group of Viruses.∗ , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[28]  R. Schnitzer,et al.  Chemotherapeutic Effect of 2-hydroxy-1,4-naphthoquinonimine on Infections of Mice with Col SK Virus , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[29]  H. Ginsberg,et al.  THERAPY OF INFECTION WITH PNEUMONIA VIRUS OF MICE (PVM) , 1951, The Journal of experimental medicine.

[30]  J. Miller,et al.  Oxidation and transamination of glutamate by typhus rickettsiae. , 1950, The Journal of biological chemistry.

[31]  D. Hamre,et al.  Activity of p-Aminobenzaldehyde, 3-Thiosemicarbazone on Vaccinia Virus in the Chick Embryo and in the Mouse , 1950 .

[32]  J. C. Snyder,et al.  RESPIRATION OF TYPHUS RICKETTSIAE , 1949, The Journal of experimental medicine.

[33]  M. Mccarty,et al.  THE MODIFYING EFFECTS OF CERTAIN SUBSTANCES OF BACTERIAL ORIGIN ON THE COURSE OF INFECTION WITH PNEUMONIA VIRUS OF MICE (PVM) , 1947, The Journal of experimental medicine.

[34]  T. Rivers,et al.  CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA , 1941, Journal of Experimental Medicine.

[35]  J. Smith,et al.  The chemotherapy of viruses. , 1955, Advances in virus research.

[36]  C. A. Knight,et al.  The chemical constitution of viruses. , 1954, Advances in virus research.

[37]  D. Peters,et al.  Untersuchungen am Virus der Variola-Vaccine , 1954 .

[38]  F. Horsfall Experiments on chemical alteration of virus infections. , 1952, The Harvey lectures.

[39]  J. Moulder,et al.  Purification and properties of the agent of feline pneumonitis. , 1951, The Journal of infectious diseases.